Stephen Dayan, MD
Anesthesiology · New Rochelle, NYNPI 1134103500
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.8% of the total across 122 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $724, 7.8 times the $92 reported in 2019. Among anesthesiology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 122 payments — averaging $20.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$398
- AbbVie$353
- Takeda Pharmaceuticals U.S.A., Inc.$279
- Johnson & Johnson$231
- Lundbeck LLC$170
- Lilly USA, LLC$156
- plus $902 from 19 others
What the payments were for
- Food & beverage$2,38496%
- Education$1044%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 21 | $398 |
| AbbVie | 22 | $353 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $279 |
| Johnson & Johnson | 12 | $231 |
| Lundbeck LLC | 10 | $170 |
| Lilly USA, LLC | 6 | $156 |
| Celltrion USA Inc. | 4 | $104 |
| Braintree Laboratories, Inc. | 5 | $94 |
| Exact Sciences | 3 | $86 |
| Neurelis, Inc. | 3 | $81 |
| Daiichi Sankyo Inc. | 4 | $77 |
| Alnylam Pharmaceuticals Inc. | 3 | $74 |
| Galderma Laboratories, L.p. | 1 | $56 |
| Merz North America, Inc. | 1 | $43 |
| Corium, LLC | 2 | $38 |
| Intercept Pharmaceuticals, Inc. | 2 | $36 |
| Dynavax Technologies Corporation | 2 | $30 |
| Grifols USA, LLC | 1 | $26 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Mirum Pharmaceuticals, Inc. | 1 | $24 |
| Redhill Biopharma Inc. | 1 | $24 |
| Sandoz | 1 | $23 |
| Ardelyx, Inc. | 1 | $22 |
| Orphalan Inc | 1 | $22 |
| Ironwood Pharmaceuticals, Inc | 1 | $18 |
How this compares
$2,488 in reported general payments places this provider in the 95th percentile of 4,157 anesthesiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anesthesiology in New Rochelle
- Mark KronenfeldBrooklyn$2.4M
- Kiran PatelNew York$832K
- Karina GritsenkoBronx$665K
- Marc DicksteinNew York$585K
- Admir HadzicNew York$510K
- Christopher DimeoNew York$449K
- Christopher RieglerNew York$429K
- William UrmeyNew York$397K
- Sudhir DiwanNew York$255K
- Daniel KatzNew York$190K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.